A Multiple Ascending Dose Study With a Dose Formulation Comparison Cohort to Evaluate the Safety, Tolerability, and Pharmacokinetics of TBA-354 in Healthy Adult Subjects

NCT02606214 · clinicaltrials.gov ↗

PHASE1

Phase

TERMINATED

Status

18

Enrollment

OTHER

Sponsor class

Stopped Clinical Hold from FDA

Conditions

Tuberculosis

Interventions

DRUG: TBA-354
DRUG: TBA-354 Placebo

Sponsor

Global Alliance for TB Drug Development